Legal Representation
Attorney
Jeffrey L. Van Hoosear
USPTO Deadlines
Next Deadline
1255 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-12-27)
Due Date
December 27, 2028
Grace Period Ends
June 27, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Dec 27, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Dec 27, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Oct 11, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 11, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Sep 21, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 7, 2022 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
Sep 2, 2022 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
Aug 29, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Aug 12, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Aug 11, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 11, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 15, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Feb 15, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Feb 15, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Feb 9, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 23, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 10, 2021 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
Jun 10, 2021 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
May 31, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, pharmaceutical preparations for scars, skin care, skin wounds, and the treatment of damaged skin and tissue; chemical products for medicinal purposes and health care, namely, chemical reagents for medical purposes and chemical preparations for scars, skin care, skin wounds, and the treatment of damaged skin and tissue; pharmaceutical drugs, namely, pharmaceuticals for the treatment of scars, skin care, skin wounds, and the treatment of damaged skin and tissue
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
CONTRACT UBEX
Classification
International Classes
005